University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis : data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry

Simple item page
dc.contributor.authorMichelena, Xabier
dc.contributor.authorZhao, Sizheng Steven
dc.contributor.authorDubash, Sayam
dc.contributor.authorDean, Linda E
dc.contributor.authorJones, Gareth T
dc.contributor.authorMarzo-Ortega, Helena
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2021-12-07T13:36:00Z
dc.date.available2021-12-07T13:36:00Z
dc.date.issued2021-12-01
dc.descriptionAcknowledgements: We acknowledge Prof. Gary J. MacFarlane as chief investigator on the BSRBR-AS study. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at www.abdn.ac.uk/bsrbr-as. H.M.O. designed the study proposal. X.M. analysed the data and wrote the manuscript, with significant input from all co-authors. G.T.J. is deputy chief investigator on the BSRBR-AS study and together with L.D. discussed results and provided input into drafts of the manuscript. The study was approved by the National Research Ethics Service Committee North East-County Durham and Tees Valley (reference 11/NE/0374) and informed consent was obtained from all participants. Funding: This work was supported by a research grant from the FOREUM Foundation for Research in Rheumatology. The BSRBR-AS is funded by the British Society for Rheumatology, which received funding for this from Pfizer, AbbVie and UCB. They have no input in determining the topics for analysis or work involved in undertaking it.en
dc.description.statusPeer revieweden
dc.format.extent6
dc.format.extent468563
dc.identifier190694150
dc.identifierdbfbbfb3-6731-43d2-bf34-c1c660b22395
dc.identifier33502476
dc.identifier85122546497
dc.identifier.citationMichelena, X, Zhao, S S, Dubash, S, Dean, L E, Jones, G T & Marzo-Ortega, H 2021, 'Similar biologic drug response regardless of radiographic status in axial spondyloarthritis : data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry', Rheumatology, vol. 60, no. 12, pp. 5795-5800. https://doi.org/10.1093/rheumatology/keab070en
dc.identifier.doi10.1093/rheumatology/keab070
dc.identifier.iss12en
dc.identifier.issn1462-0324
dc.identifier.otherORCID: /0000-0003-0016-7591/work/93483283
dc.identifier.urihttps://hdl.handle.net/2164/17630
dc.identifier.vol60en
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectankylosing spondylitisen
dc.subjectepidemiologyen
dc.subjectbiological therapyen
dc.subjectdrug survivalen
dc.subjectaxial spondyloarthritisen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleSimilar biologic drug response regardless of radiographic status in axial spondyloarthritis : data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registryen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Michelena_etal_E_Similar_Biologic_Drug_VoR.pdf
Size:
457.58 KB
Format:
Adobe Portable Document Format
Download

Collections

All research